|Bid||320.32 x 800|
|Ask||324.18 x 900|
|Day's range||317.01 - 322.36|
|52-week range||203.04 - 323.61|
|Beta (5Y monthly)||0.43|
|PE ratio (TTM)||25.21|
|Earnings date||24 Jan 2023 - 30 Jan 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||324.62|
Here's why they think that AbbVie (NYSE: ABBV), Exelixis (NASDAQ: EXEL), and Vertex Pharmaceuticals (NASDAQ: VRTX) are stocks to buy hand over fist in December. Prosper Junior Bakiny (AbbVie): The end of the year is always a great time to review your investment portfolio. The drugmaker is set to lose U.S. patent protection for its biggest cash cow -- autoimmune-disease medicine Humira -- next year.
Long-time shareholders of these companies can testify that both have patterns of beating the market.
The number 12 is tightly linked with December. It's the 12th month, of course. There are 12 days of Christmas, according to the traditional carol. Allow me to add one more connection with 12 to the list.